High uptake of RSVpreF vaccine and nirsevimab was observed, with 64% of pregnant individuals and 70% of infants receiving ...
Early results from a trial testing a 2009 H1N1 influenza vaccine in children look promising, according to the trial sponsor, the National Institute of Allergy and Infectious Diseases (NIAID), part ...
The minister said, "The research on a vaccine for cancers that affect women is nearly complete, and trials are underway. It will be available in five to six months, and girls in the age group of ...